Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.69 is 46% below its 5-year average of 1.29, near the low end of its 5-year range (0.50–3.50).
As of the fiscal period ended Tuesday, June 30, 2026. 0.08% below its 12-month average of 0.69.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.69.
CURRENT RATIO
0.69
CURRENT RATIO AVG TTM
0.69
CURRENT RATIO AVG 3Y
1.29
CURRENT RATIO AVG 5Y
1.29
CURRENT RATIO AVG 10Y
0.97
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.08%
CURRENT VS 3Y AVG
-46.37%
CURRENT VS 5Y AVG
-46.48%
CURRENT VS 10Y AVG
-28.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 730 covered companies
CURRENT VS SECTOR MEDIAN
-80.51%
vs the sector median at left
Market Cap
$2.57M
Current Ratio
1.44
TTM Avg
1.74
3Y Avg
3.93
5Y Avg
2.64
Market Cap
$2.52M
Current Ratio
2.64
TTM Avg
2.37
3Y Avg
1.52
5Y Avg
1.27
Market Cap
$2.39M
Current Ratio
12.91
TTM Avg
22.35
3Y Avg
19.50
5Y Avg
14.70
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jaguar Health, Inc. (JAGX) | $2.55M | 0.69 | 0.69 | 1.29 | 1.29 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.57M | 1.44 | 1.74 | 3.93 | 2.64 |
| Nuwellis, Inc. (NUWE)vs › | $2.59M | 1.97 | 2.58 | 3.16 | 4.38 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | 2.64 | 2.37 | 1.52 | 1.27 |
| iSpecimen Inc. (ISPC)vs › | $2.64M | 0.82 | 0.87 | 1.93 | 3.50 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.43M | 0.94 | 1.19 | 3.93 | 6.93 |
| Onconetix, Inc. (ONCO)vs › | $2.37M | 2.21 | 0.36 | 1.94 | 12.76 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.39M | 12.91 | 22.35 | 19.50 | 14.70 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.25M | 1.54 | 2.65 | 3.41 | 4.73 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.00M | 1.41 | 2.85 | 1.58 | 2.33 |
Current Ratio
0.69
Quick Ratio
0.40
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.69 |
| 2026-03-31 | 0.50 |
| 2025-12-31 | 0.50 |
| 2025-09-30 | 0.81 |
| 2025-06-30 | 0.95 |
| 2025-03-31 | 1.08 |
| 2024-12-31 | 1.63 |
| 2024-09-30 | 1.84 |
| 2024-06-30 | 2.10 |
| 2024-03-31 | 1.89 |
| 2023-12-31 | 2.00 |
| 2023-09-30 | 1.77 |
| 2023-06-30 | 0.97 |
| 2023-03-31 | 1.04 |
| 2022-12-31 | 0.74 |
| 2022-09-30 | 0.94 |
| 2022-06-30 | 1.02 |
| 2022-03-31 | 1.49 |
| 2021-12-31 | 1.84 |
| 2021-09-30 | 2.01 |
| 2021-06-30 | 3.50 |
| 2021-03-31 | 3.50 |
| 2020-12-31 | 1.35 |
| 2020-09-30 | 0.42 |
| 2020-06-30 | 0.47 |
| 2020-03-31 | 0.42 |
| 2019-12-31 | 0.62 |
| 2019-09-30 | 0.88 |
| 2019-06-30 | 0.35 |
| 2019-03-31 | 0.30 |
| 2018-12-31 | 0.31 |
| 2018-09-30 | 0.46 |
| 2018-06-30 | 0.56 |
| 2018-03-31 | 1.16 |
| 2017-12-31 | 0.25 |
| 2017-09-30 | 0.26 |
| 2017-06-30 | 0.38 |
| 2017-03-31 | 0.31 |
| 2016-12-31 | 0.61 |
| 2016-09-30 | 1.32 |
| 2016-06-30 | 1.70 |
| 2016-03-31 | 2.20 |
| 2015-12-31 | 2.16 |
| 2015-09-30 | 2.91 |
| 2015-06-30 | 4.69 |
| 2015-03-31 | 0.43 |
| 2014-12-31 | 1.75 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 4.19 |
| 2014-03-31 | 0.00 |